Anzeige
Mehr »
Login
Samstag, 18.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Spezial Report: NASDAQ-FinTech mit 3.000% Wachstum und 500% Kurs-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
24 Leser
Artikel bewerten:
(0)

Cell Press Helps Authors Share Papers Under Consideration

AMSTERDAM, March 30, 2017 /PRNewswire/ --

Recognizing that science benefits from communicating reliable, vetted findings as quickly as possible, Cell Press now offers authors the opportunity to surface their submitted manuscript as soon as it has been evaluated by an editor and sent out for peer review. The service is called "Cell Press Sneak Peek." For authors who elect to participate, manuscripts under consideration by peer reviewers will be uploaded on the authors' behalf to the Sneak Peak group on Mendeley, an academic social network, where it will be freely accessible to all interested readers. To have a look, visit https://www.mendeley.com/sneak-peek/cellpress/

"We hear every day from authors about how happy they are when their manuscript is sent out for review and also how frustrated they are about how long it takes to publish these days. Putting these two together, we have created an opportunity for authors to get recognition for their work being peer reviewed at a Cell Press journal," says Cell Press CEO Emilie Marcus.

"The new 'Sneak Peek' service from Cell Press is a great way for authors to gain visibility and credit for their work well in advance of formal publication," says Seamus Martin, the Smurfit Chair of Medical Genetics at Trinity College Dublin and a member of the Cell Reports editorial board. "Of course, readers will also benefit hugely by being able to read what's in the pipeline at a much earlier stage of the publication process. One thing is for sure, I shall certainly be sneaking a peek!"

"Cell Press Sneak Peek" is part of a series of new services Cell Press is offering researchers. Last year, the publisher premiered "STAR Methods," which promotes guidelines encouraged by reagent labeling and animal experimentation initiatives (http://www.cell.com/star-methods).

Cell Press (@CellPressNews), an imprint of Elsevier, is a leading publisher of scientific research and reviews. We drive science forward and promote cross-pollination of ideas with our passion for excellence and commitment to innovation. Our aim is to engage the scientific community by communicating important, exciting discoveries made today that will impact the future of research. Visit www.cell.com .

Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries.www.elsevier.com

Media contact
Joseph Caputo
Press Office, Cell Press
+1-617-397-2802
jcaputo@cell.com
press@cell.com

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.